Literature DB >> 21653742

OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice.

Wendy Gaisford1, David I Pritchard, Anne Cooke.   

Abstract

Some infectious diseases have been shown to halt the onset of autoimmune disease in animal models and have been suggested to also influence autoimmune pathology in humans. The isolation and study of small molecules and proteins from the infectious agents responsible for the protective effect will enable a mechanistic understanding of how these components may prevent or delay the onset of autoimmunity. In this study we confirm that the quorum-sensing signal molecule OdDHL from Pseudomonas aeruginosa can delay the onset of type 1 diabetes in the NOD mouse model. Furthermore, using an antigen-presenting cell-free system, we find not only that OdDHL inhibits the proliferation of naïve T cells but also that it directly inhibits the differentiation of T cell subsets. OdDHL was shown to have no effect on the inhibition of primed and committed differentiated T cell responses, suggesting that that immune mechanism mediated by this molecule may be more restricted to initial stages of infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653742      PMCID: PMC3147336          DOI: 10.1128/CVI.00032-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

1.  The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-cell activation.

Authors:  A J Ritchie; A Jansson; J Stallberg; P Nilsson; P Lysaght; M A Cooley
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone.

Authors:  D I Pritchard; I Todd; A Brown; B W Bycroft; S R Chhabra; P Williams; P Wood
Journal:  Acta Diabetol       Date:  2005-10       Impact factor: 4.280

3.  Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes.

Authors:  Marie-Alexandra Alyanakian; Françoise Grela; Aude Aumeunier; Carlo Chiavaroli; Christine Gouarin; Emilie Bardel; Gérard Normier; Lucienne Chatenoud; Nathalie Thieblemont; Jean-François Bach
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

Review 4.  Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.

Authors:  Steven Tracy; Kristen M Drescher
Journal:  Ann N Y Acad Sci       Date:  2007-03-21       Impact factor: 5.691

5.  A role for CD45RBlow CD38+ T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes.

Authors:  T C Martins; A P Aguas
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

6.  Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Sven Brode; Tim Raine; Paola Zaccone; Anne Cooke
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

7.  The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity.

Authors:  G Telford; D Wheeler; P Williams; P T Tomkins; P Appleby; H Sewell; G S Stewart; B W Bycroft; D I Pritchard
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

8.  Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.

Authors:  Kristen M Drescher; Ken Kono; Shubhada Bopegamage; Steven D Carson; Steven Tracy
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

9.  Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice.

Authors:  Paola Zaccone; Tim Raine; Stéphane Sidobre; Mitchell Kronenberg; Pietro Mastroeni; Anne Cooke
Journal:  Eur J Immunol       Date:  2004-11       Impact factor: 5.532

10.  The immunomodulatory Pseudomonas aeruginosa signalling molecule N-(3-oxododecanoyl)-L-homoserine lactone enters mammalian cells in an unregulated fashion.

Authors:  Adam J Ritchie; Christine Whittall; James J Lazenby; Siri Ram Chhabra; David I Pritchard; Margaret A Cooley
Journal:  Immunol Cell Biol       Date:  2007-07-03       Impact factor: 5.126

View more
  3 in total

Review 1.  Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.

Authors:  Lan Lin; Jianqiong Zhang
Journal:  BMC Immunol       Date:  2017-01-06       Impact factor: 3.615

2.  Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics.

Authors:  Tae Kang Kim; June-Chul Lee; Sin-Hyeog Im; Myung-Shik Lee
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561

Review 3.  Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections.

Authors:  Luke L Proctor; Whitney L Ward; Conner S Roggy; Alexandra G Koontz; Katie M Clark; Alyssa P Quinn; Meredith Schroeder; Amanda E Brooks; James M Small; Francina D Towne; Benjamin D Brooks
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.